Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Comment by Liked2Thinkon Mar 03, 2022 10:52am
118 Views
Post# 34479059

RE:Closing of CAD$1.87 Million Private Placement

RE:Closing of CAD$1.87 Million Private PlacementTalk about a pathetic PP

Exercise price of a penny higher than what it is today! haha

The next PP will be 11 cents, half of what this one was which was half of the last one.  Thats a good trend!

They should add a portion to this NR stating

"Upon closing of the PP Stage will begin looking for the next sucker to give us money a month from now as we will be clean out of cash by then again"

Maybe Tripp should let us have that $30M he said they had in revenue years ago.  Maybe any part of the $20M "deal" with Oncore?  How about that $60M deal Oncore had with iBodyCheck?  Im sure Oncore will be the cornerstone of the "lab in Europe" BS
<< Previous
Bullboard Posts
Next >>